Edarbi 20mg
Edarbi 20mg is a medicine authorised by Swissmedic under authorisation number 62158. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 August 2012 and the authorisation is valid without a time limit. ATC code C09CA09 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 62158 |
|---|---|
| Name | Edarbi 20mg |
| Full name | Edarbi 20mg, Tabletten |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09CA09 |
| First authorisation | 31 August 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Edarbi 20mg, Tabletten | B | 31 August 2012 |
| 2 | Edarbi 40mg, Tabletten | B | 31 August 2012 |
| 3 | Edarbi 80mg, Tabletten | B | 31 August 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 3 | 98 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 16 | 14 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 4 | 28 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 6 | 98 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 17 | 14 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 7 | 28 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 9 | 98 | Tablette(n) | C09CA09 | 02.07.1. | B |
| 18 | 14 | Tablette(n) | C09CA09 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Edarbi 20mg authorised in Switzerland?
Yes. Edarbi 20mg is authorised by Swissmedic under authorisation number 62158, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Edarbi 20mg have?
Edarbi 20mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Edarbi 20mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.